Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer
Yu‐Yang Bi(China Pharmaceutical University), Hu‐Lin Jiang(China Pharmaceutical University)
Cited by 49
Related Papers
Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor
|Toxicology and Applied Pharmacology|2017|44